In the multivariate Cox regression analysis (Table 3), BAX mRNA expression predicted a significantly favorable prognostic outcome (HR = 0.33, 95% CI = 0.13–0.84, P = 0.020), independent of patients’ gender, age, tumor histology, tumor extent, and regional lymph node status. The gene discussed is BAX; the disease is neoplasm.